Literature DB >> 15159643

A new, low-volume protein substitute for teenagers and adults with phenylketonuria.

A MacDonald1, M Lilburn, B Cochrane, P Davies, A Daly, D Asplin, S K Hall, A Cousins, A Chakrapani, P Robinson, P Lee.   

Abstract

Some older patients with phenylketonuria (PKU) fail to consume their protein substitute (with or without vitamin and mineral supplements) in prescribed amounts, which contributes to poor blood phenylalanine control. PKU Express (Vitaflo), is a new low-volume (amino acids 72 g/100 g), low-carbohydrate, phenylalanine-free protein substitute with added vitamins and minerals designed for people with PKU over 8 years of age. In an open intervention study, the aim was to investigate its acceptability and effectiveness in a group of teenagers and adults with PKU. Twenty-three subjects (15 female; 8 male) with PKU, who had a median age of 17 years (range 8-37 years) took the substitute for 8 weeks. A 3-day prospective diet diary, height, weight, plasma amino acids, biochemical and haematological nutritional analytes were measured at weeks 0 and 8. Skin-puncture bloods for plasma phenylalanine were collected every 2 weeks. The median weight of protein substitute (with or without vitamin and mineral supplements) consumed decreased by 33% from 150 g (range 140-180) daily to 100 g (range 100-125) daily ( p <0.001). Median change in energy intake decreased by a median of 10% (95% CI 2.0 to 18.0) when compared to intake on original protein substitute. On PKU Express, the intakes of all nutrients exceeded the dietary reference values but none was excessively high. Blood phenylalanine decreased by a mean of 37 micromol/L (95% CI-27 to 102) during the trial. Body mass index decreased in 40% of subjects. Changes in blood phenylalanine or body mass index were not statistically significant. Most of the nutritional, haematological and biochemical indices stayed within normal reference ranges for the analytes studied. Sixteen (70%) of the subjects had low plasma selenium at the start, but only 13 (57%) at the study end. Plasma vitamin B12 was high in 8 subjects at the start of the study and 9 at the end. Twenty-one subjects (96%) stated that the product was convenient and easy to prepare. However, 7 (32%) described the smell and 9 (46%) the texture as the same as or worse than those of previous protein substitutes. Because of the use of the premeasured sachets, some subjects were able to prepare their own protein substitute for the first time. PKU Express is a safe, efficacious, protein substitute that significantly reduces the daily volume of prescribed protein substitute.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15159643     DOI: 10.1023/B:BOLI.0000028784.11080.9b

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  8 in total

1.  Dietary control of phenylketonuria.

Authors:  Helen Mundy; Maggie Lilburn; Alison Cousins; Philip Lee
Journal:  Lancet       Date:  2002 Dec 21-28       Impact factor: 79.321

2.  Phenylketonuria treated with a high phenylalanine intake and casein-hydrolysate/aminoacid mixtures.

Authors:  S O'DALY
Journal:  Lancet       Date:  1961-06-24       Impact factor: 79.321

Review 3.  National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000.

Authors: 
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

4.  Nutrient intake and food consumption of adolescents and young adults with phenylketonuria.

Authors:  B Schulz; H J Bremer
Journal:  Acta Paediatr       Date:  1995-07       Impact factor: 2.299

5.  Vitamin B12 deficiency in adolescents and young adults with phenylketonuria.

Authors:  W B Hanley; A S Feigenbaum; J T Clarke; W E Schoonheyt; V J Austin
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

6.  A new approach to the treatment of phenylketonuria.

Authors:  O E Pratt
Journal:  J Ment Defic Res       Date:  1980-09

7.  Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria.

Authors: 
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

8.  How practical are recommendations for dietary control in phenylketonuria?

Authors:  J H Walter; F J White; S K Hall; A MacDonald; G Rylance; A Boneh; D E Francis; G J Shortland; M Schmidt; A Vail
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

  8 in total
  9 in total

1.  A new protein substitute for adolescents and adults with maple syrup urine disease (MSUD).

Authors:  P Hallam; M Lilburn; P J Lee
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  'Ready to drink' protein substitute is easier is for people with phenylketonuria.

Authors:  A MacDonald; M Lilburn; P Davies; S Evans; A Daly; S K Hall; C Hendriksz; A Chakrapani; P Lee
Journal:  J Inherit Metab Dis       Date:  2006-05-30       Impact factor: 4.982

Review 3.  Nutritional issues in treating phenylketonuria.

Authors:  François Feillet; Carlo Agostoni
Journal:  J Inherit Metab Dis       Date:  2010-02-12       Impact factor: 4.982

Review 4.  Protein substitutes for PKU: what's new?

Authors:  A Macdonald; A Daly; P Davies; D Asplin; S K Hall; G Rylance; A Chakrapani
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

5.  Protein substitute dosage in PKU: how much do young patients need?

Authors:  A MacDonald; A Chakrapani; C Hendriksz; A Daly; P Davies; D Asplin; K Hall; I W Booth
Journal:  Arch Dis Child       Date:  2006-03-17       Impact factor: 3.791

6.  Long-term compliance with a novel vitamin and mineral supplement in older people with PKU.

Authors:  A MacDonald; P Lee; P Davies; A Daly; M Lilburn; H Gokmen Ozel; M A Preece; C Hendriksz; A Chakrapani
Journal:  J Inherit Metab Dis       Date:  2008-10-22       Impact factor: 4.982

Review 7.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

8.  Special Low Protein Foods in the UK: An Examination of Their Macronutrient Composition in Comparison to Regular Foods.

Authors:  Georgina Wood; Sharon Evans; Kiri Pointon-Bell; Júlio César Rocha; Anita MacDonald
Journal:  Nutrients       Date:  2020-06-25       Impact factor: 5.717

Review 9.  Protein Substitutes in PKU; Their Historical Evolution.

Authors:  Anne Daly; Sharon Evans; Alex Pinto; Catherine Ashmore; Anita MacDonald
Journal:  Nutrients       Date:  2021-02-02       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.